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We read with interest the article by Xie and colleagues
reporting the impact of invasive fungal infection (IFI) on
outcomes [1]. In a cohort of 318 intensive care unit patients
with severe sepsis they found 90 patients with IFI (28.3%).
Ninety-three per cent of the IFIs were caused by Candida
species, 3% by Aspergillus species and 4% were unclassi-
fied. Predominant sites of infection were the lung (56.4%) and
the abdomen (22.7%). As such, Candida pneumonia was the
most frequent type of infection in this cohort, representing
53.6% of all IFIs (we assume that all cases of aspergillosis
were pulmonary). This is most remarkable as the presence of
Candida in respiratory tract cultures is seldom pathogenic and
Candida pneumonia is considered a rare disease entity in
which the diagnosis can only be made by histological
confirmation [2]. The same remark is valid for intra-abdominal
IFI. The presence of Candida from intraabdominal cultures
does not necessarily represent Candida peritonitis [3].
The authors point out that histological confirmation was often
impossible due to coagulation disorders. We acknowledge
the risk of biopsy sampling in critically ill patients [4,5].
Nevertheless, in Xie and colleagues’ study the degree of
diagnostic validation of IFI is poor and we question the true
incidence of Candida pneumonia and peritonitis. As such,
mixing IFIs with fungal colonization might have influenced the
results. We therefore invite Xie and colleagues to report the
incidence of truly confirmed invasive IFI and to make a
comparison in mortality with cases of presumed IFI.
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IFI = invasive fungal infection.
Authors’ response
Guohao Xie and Xiangming Fang
We thank Blot and colleagues for their critical comments. We
agree that histological conformation is the gold standard for
diagnosis of IFI and it is difficult to discriminate IFI from
colonization without biopsy. Since haemodynamic and/or
respiratory insufficiency and coagulopathy are common in
critically ill patients, the risks of biopsy preclude histological
conformation in most patients. We therefore established
several criteria to capture IFI patients without biopsy, as
described in our study [1]. Similarly, Vandewoude and
colleagues established a diagnostic algorithm based upon
clinical manifestations, imaging data and microbiological
findings to assess invasive aspergillosis without biopsy [5].
Among the 90 patients with IFI in our study, 21 with
confirmed IFI had a comparable hospital mortality to the
remaining 69 patients with presumed IFI (76% versus 65%,
P = 0.43). The 69 cases with presumed IFI, however, had not
been further validated since autopsy was refused by all of
their families. This may lead to an overdiagnosis of IFI in these
patients, which we have acknowledged as the major limitation
in our article.
We believe that, despite histological conformation, a diag-
nostic algorithm of IFI based upon clinical manifestations,
imaging data and microbiological findings still needs to be
established in the future for clinical practice and epidemio-
logical studies.Page 2 of 2
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